Oncolytics Biotech Inc.

(ONCY) Trade

By |

Profile

Oncolytics Biotech Inc is a development stage biotechnology company. It focuses on discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its main product is Reolysin. The company also has patents issued worldwide, mainly in US and Canada. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives.

Contact Information

Website: www.oncolyticsbiotech.com
Email: mmoore@oncolytics.ca
Main Phone: +1 403 670-7377
Address: 1167 Kensington Crescent North West
Address 2: Suite 210
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T2N 1X7

Issuer Information

Exchange: NSC
CEO: Matthew C. Coffey
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Oncolytics Biotech Inc is a development stage biotechnology company. It focuses on discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its main product is Reolysin. The company also has patents issued worldwide, mainly in US and Canada. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives.

Contact Information

Website: www.oncolyticsbiotech.com
Email: mmoore@oncolytics.ca
Main Phone: +1 403 670-7377
Address: 1167 Kensington Crescent North West
Address 2: Suite 210
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T2N 1X7

Issuer Information

Exchange: NSC
CEO: Matthew C. Coffey
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.49 $ 0.0248 (5.33%)
Last Price 0.49 Change $ 0.0248 Change % 5.33 Tick N/A
Bid 0.48 Bid Size 600.00 Ask 0.54 Ask Size 2,500.00
Open 0.48 High 0.51 Low 0.47 Prev Close 0.47
Last Trade Volume 252,840 52 Wk Hi 3.20 52 Wk Low 0.35
Market Cap 12.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 25,010,089.00 EPS (TTM) -0.65 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16.71 16.71 1.76 16.71
Low Target Price Estimate 16.71 16.71 1.76 16.71
Mean Target Price Estimate 16.71 16.71 1.76 16.71
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/14/18 05/14/18 05/14/18 05/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.5 2.5 2.5 2.5